Fabry's disease with LVOT obstruction: diagnosis and management

Jacob R Blount1, James K Wu, Matthew W Martinez

  • 1University of South Florida Morsani College of Medicine, USF LVHN SELECT Program, Lehigh Valley Health Network, Tampa, Florida.

Journal of Cardiac Surgery
|September 3, 2013
PubMed

Insights

Genetic testing identified Fabry's disease, an HCM mimic, in a patient with severe left ventricular outflow tract obstruction. This case highlights genetic testing

Area of Science:

  • Cardiology
  • Genetics
  • Rare Diseases

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic heart condition.
  • Left ventricular outflow tract (LVOT) obstruction is a common complication of HCM.

Observation:

  • A 46-year-old male presented with symptoms of severe LVOT obstruction.
  • Initial diagnosis was HCM, but genetic testing revealed Fabry's disease.
  • The patient had no other clinical manifestations of Fabry's disease.

Findings:

  • Genetic testing is crucial for differentiating HCM mimics.
  • Fabry's disease can present solely with cardiac manifestations, mimicking HCM.
  • Surgical myectomy provided symptom relief for the patient.

Implications:

  • This case underscores the importance of genetic testing in diagnosing cardiac conditions.
  • Early diagnosis of Fabry's disease can guide appropriate management.
  • Recognizing HCM mimics prevents misdiagnosis and ensures timely, effective treatment.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.